Cancer News and Research

Latest Cancer News and Research

Mayo Clinic, St. Andrew's Lighthouse announce opening of Gabriel House of Care

Mayo Clinic and St. Andrew's Lighthouse, Inc. will today announce the official opening of Gabriel House of Care at a dedication ceremony on the clinic's Jacksonville campus.

18 Mar 2011

Science journal publishes CYTK preclinical cardiac myosin activation research results

Cytokinetics, Incorporated announced today the publication of preclinical research in the March 18, 2011 issue of the journal Science regarding the activation of cardiac myosin by an investigational drug candidate, omecamtiv mecarbil, and the potential therapeutic role that this novel mechanism may play for patients with systolic heart failure.

18 Mar 2011

Modified mRNA raises hope for safe and effective cancer drugs

Modern gene therapies raise hopes of combating many diseases until now considered terminal. Nowadays, however, the methods are expensive and carry a risk of severe complications.

18 Mar 2011

Scientists develop California's first detailed neighborhood database on cancer

Does living in a low-income, densely populated neighborhood such as San Francisco's Tenderloin district predispose you to a higher cancer risk than if you live in an upscale and suburban neighborhood such as San Diego's Rancho Santa Fe? Or vice versa? Scientists at the Cancer Prevention Institute of California now have the data that hold the answers.

18 Mar 2011

FDA advisory panel votes in favor of NovoTTF-100A System for supra-tentorial glioblastoma multiforme tumors

Novocure announced today that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted (7 yes; 3 no; 2 abstain) that for patients with supra-tentorial glioblastoma multiforme (GBM) tumors that recur after maximal surgical and radiation treatments, there is reasonable assurance that the benefits of the NovoTTF-100A System (NovoTTF) outweigh its risks when administered as a monotherapy in place of standard medical therapy.

18 Mar 2011

Study: Stem cells may open door to new tools for colorectal cancer detection, treatment

Colorectal cancer cells trigger a set of genes similar to those found in intestinal stem cells, scientists at the Institute for Research in Biomedicine have found.

18 Mar 2011

Major clinical studies for heart disease, stroke fail to consider participant's ethnicity

Major clinical studies that evaluate prevention strategies for heart disease and stroke fail to consider a participant's ethnicity, a factor that can more than double the rate of death in some groups, according to research led by St. Michael's Dr. Joel Ray.

18 Mar 2011

Individualized dentritic cell vaccine may increase survival time in patients with glioblastoma

A dendritic cell vaccine personalized for each individual based on the patient's own tumor may increase median survival time in those with a deadly form of brain cancer called glioblastoma, an early phase study at UCLA's Jonsson Comprehensive Cancer Center has found.

18 Mar 2011

Vitamin A may play key role in sperm cell formation and development of central nervous system

In a recently-published study mapping the structure and function of the so-called "orphan" nuclear receptor TR4, Van Andel Research Institute (VARI) investigators suggest that Vitamin A may play a more direct role than was previously known in certain physiological functions including sperm cell formation and the development of the central nervous system.

18 Mar 2011

Scientists receive £5million EU grant to identify gene targets for kidney cancer treatment

An international consortium led by scientists from the Cancer Research UK London Research Institute, The Royal Marsden Hospital and the Technical University of Denmark has been granted nearly £5million by the European Union to identify gene targets for personalised treatment for kidney cancer patients.

18 Mar 2011

INEN, MD Anderson sign sister institution agreement

The University of Texas MD Anderson Cancer Center today signed a sister institution agreement with the National Cancer Institute of Peru. Also known as the Instituto Nacional de Enfermedades Neoplásicas, INEN is Peru's sole national referral center for cancer.

18 Mar 2011

Quest Diagnostics ColoVantage molecular colorectal cancer detection test receives New York State approval

Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.

From Quest Diagnostics 18 Mar 2011

BUSM scientists identify new biomarker and melanoma treatment target

Researchers at Boston University School of Medicine, in collaboration with Johns Hopkins University, have identified a potential new biomarker and therapeutic target for melanoma.

18 Mar 2011

FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of anemia in chronic kidney disease

FibroGen, Inc., today announced that FibroGen and partner Astellas Pharma Inc. advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis.

18 Mar 2011

St. Michael's receives $5 million McCain donation for therapeutic endoscopy program

Wallace and Margaret McCain have donated $5 million to St. Michael's Hospital for its therapeutic endoscopy program.

18 Mar 2011

AICR awards £179,532 grant to Van Andel Research Institute for prostate cancer research

Research by scientists in America, funded by an international charity based in Scotland, could lead to new drugs for prostate cancer.

17 Mar 2011

GenSpera strengthens intellectual property for second prostate cancer drug

GenSpera, Inc. announced that its patent application, entitled "Activation of Peptide Prodrugs by HK2," has been issued by the United States Patent and Trademark Office (USPTO) as US Patent 7,906,477.

17 Mar 2011

CytRx commences INNO-206 Phase 1b trial in advanced solid tumors

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California. The clinical trial will include up to 24 patients with advanced solid tumors who have failed standard therapies.

17 Mar 2011

'Fetus To Fifth Grade' book provides updated research on pregnancy and childcare

Recent scientific studies have brought into sharp focus the importance of, and exactly what type of, mother/child interaction leads to an optimal outcome for the child.

17 Mar 2011

CBAI to operate its own business strategies

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today the focus of the Company on a go forward basis is to operate entirely off its own cash flow.

17 Mar 2011

Cancer News and Research

Latest Cancer News and Research

Mayo Clinic, St. Andrew's Lighthouse announce opening of Gabriel House of Care

Science journal publishes CYTK preclinical cardiac myosin activation research results

Modified mRNA raises hope for safe and effective cancer drugs

Scientists develop California's first detailed neighborhood database on cancer

FDA advisory panel votes in favor of NovoTTF-100A System for supra-tentorial glioblastoma multiforme tumors

Study: Stem cells may open door to new tools for colorectal cancer detection, treatment

Major clinical studies for heart disease, stroke fail to consider participant's ethnicity

Individualized dentritic cell vaccine may increase survival time in patients with glioblastoma

Vitamin A may play key role in sperm cell formation and development of central nervous system

Scientists receive £5million EU grant to identify gene targets for kidney cancer treatment

INEN, MD Anderson sign sister institution agreement

Quest Diagnostics ColoVantage molecular colorectal cancer detection test receives New York State approval

BUSM scientists identify new biomarker and melanoma treatment target

FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of anemia in chronic kidney disease

St. Michael's receives $5 million McCain donation for therapeutic endoscopy program

AICR awards £179,532 grant to Van Andel Research Institute for prostate cancer research

GenSpera strengthens intellectual property for second prostate cancer drug

CytRx commences INNO-206 Phase 1b trial in advanced solid tumors

'Fetus To Fifth Grade' book provides updated research on pregnancy and childcare

CBAI to operate its own business strategies

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in